Immuron (IMRN) Invested Capital (2016 - 2025)
Immuron's quarterly Invested Capital came in at $80318.3 in Q3 2025, down 36.8% year-on-year from $127094.4 in Q3 2024, and down 98.71% quarter-over-quarter from $6.2 million in Q2 2025.
Immuron has reported Invested Capital for 10 years, with the latest figure at $80318.3 in Q3 2025.
- For the quarter ending Q3 2025, Invested Capital fell 36.8% year-over-year to $80318.3; the trailing twelve-month figure through Sep 2025 stood at $80318.3 (down 36.8% YoY), and the FY2025 full-year result was $80318.3, down 36.8% from the prior year.
- Invested Capital for Q3 2025 stood at $80318.3, down from $6.2 million in the prior quarter.
- The five-year high for Invested Capital was $16.1 million in Q3 2022, with the low at $80318.3 in Q3 2025.
- Average Invested Capital over 5 years is $6.4 million, with a median of $6.2 million recorded in 2025.
- Year-over-year, Invested Capital jumped 6198.4% in 2022 and slumped 99.25% in 2023.
- Tracing IMRN's Invested Capital over 5 years: stood at $241776.6 in 2021, then jumped by 6198.4% to $15.2 million in 2022, then tumbled by 99.25% to $114095.9 in 2023, then soared by 5826.24% to $6.8 million in 2024, then sank by 98.81% to $80318.3 in 2025.
- The last three Invested Capital figures came in at $80318.3 (Q3 2025), $6.2 million (Q2 2025), and $6.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 80,318.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 80,318.33 |
| Jun 30, 2025 | 6.23 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 9, 2024 | 127,094.44 |
| Jun 30, 2024 | 9.90 Mn |
| Dec 31, 2023 | 114,095.94 |
| Sep 28, 2023 | 12.86 Mn |
| Jun 30, 2023 | 13.77 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Aug 31, 2022 | 16.12 Mn |
| Jun 30, 2022 | 918,508.44 |
| Dec 31, 2021 | 241,776.56 |
| Jun 30, 2021 | 376,778.25 |
| Dec 31, 2020 | 285,406.46 |
| Jun 30, 2020 | 3.85 Mn |
| Dec 31, 2019 | 56,439.13 |
| Jun 30, 2019 | 5.91 Mn |
| Dec 31, 2018 | 7.18 Mn |
| Jun 30, 2018 | 6.91 Mn |
| Dec 31, 2017 | 4.06 Mn |
| Sep 28, 2017 | 178,246.74 |
| Aug 31, 2017 | 226,000.00 |
| Jun 30, 2017 | 4.99 Mn |
| Dec 31, 2016 | 4.58 Mn |